Back to PPHM Stock Lookup

PPHM – Analyst Ratings

Mar 14, 2014 02:14 PM Roth Reaffirms Peregrine Pharma (PPHM) at Buy; Prelim. Bavituximab + Sorafenib Phase I/II is Positive
Mar 7, 2014 12:06 PM Peregrine (PPHM) Risk/Reward Still Favorable; Plenty to Look Forward to in FY14 - Roth
Mar 5, 2013 04:34 PM Piper Jaffray Starts Peregrine Pharmaceuticals (PPHM) at Overweight
Jan 7, 2013 08:50 AM Roth Capital Upgrades Peregrine Pharmaceuticals (PPHM) to Buy
Sep 24, 2012 09:19 AM Roth Capital Downgrades Peregrine Pharmaceuticals (PPHM) to Neutral
Sep 10, 2012 07:55 AM Peregrine Pharmaceuticals (PPHM) Price Target Nearly Doubled
Aug 15, 2012 10:17 AM Peregrine Pharmaceuticals (PPHM) Falls Despite Positive Mention
Mar 12, 2012 08:53 AM Roth Capital removed Peregrine Pharmaceuticals (PPHM) from its Focus List
Aug 30, 2011 09:03 AM JMP Securities Starts Peregrine Pharmaceuticals (PPHM) at Market Outperform
Jun 9, 2006 10:10 AM House and Senate Negotiators agreed on $2.3B Avian Flu Funding - Analyst

Back to PPHM Stock Lookup